A PHASE 3, SINGLE-ARM TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY CHILDREN 15 MONTHS THROUGH 17 YEARS OF AGE

Project: Research project

Project Details

StatusFinished
Effective start/end date1/4/21 → 1/3/23

Funding

  • Pfizer, Inc ( Award # ): $8,658.00